Portal de Periódicos da CAPES

In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection

2012; Oxford University Press; Volume: 100; Issue: 3 Linguagem: Inglês

10.1002/bjs.8955

1365-2168

Wolfram Trudo Knoefel, I Gábor, Alexander Rehders, A. Alexander, M. Krausch, Jan Schulte Am Esch, G. Fürst, Stefan A. Topp,

Liver physiology and pathology

Abstract Background Portal vein embolization (PVE) has become a standard procedure to increase the future liver remnant (FLR) and enable curative resection of initially unresectable liver tumours. This study investigated the safety and feasibility of a new two-stage liver resection technique that uses in situ liver transection (ISLT) and portal vein ligation before completion hepatectomy. Methods A consecutive series of patients undergoing ISLT and extended right hepatectomy between 2009 and 2011 were compared with consecutive patients undergoing extended right hepatectomy after PVE. All patients had initially unresectable primary or secondary liver tumours, owing to an insufficient FLR (liver segments II/III). Results Fifteen patients who had PVE and seven who underwent ISLT before extended right hepatectomy were evaluated. ISLT induced rapid growth of the FLR within 3 days, particularly after insufficient PVE, from a mean(s.d.) of 293(58) ml to 477(85) ml, corresponding to a volume increase of 63(29) per cent. All patients who had ISLT underwent completion extended right hepatectomy within 8 days (range 4–8 days). Conclusion ISLT is an effective and reliable technique to induce rapid growth of the FLR, even in patients with insufficient volume increase after PVE.